Seminars in Hematology
Volume 44, Issue 4 , Pages 227-233, October 2007

High-Dose Treatment With Autologous Stem Cell Transplantation in Multiple Myeloma: Past, Present, and Future

  • Bo Björkstrand

      Affiliations

    • Corresponding Author InformationAddress correspondence to Bo Björkstrand, MD, PhD, Hematology Center, M54, Karolinska University Hospital Huddinge, SE-14186 Stockholm, Sweden.
    • ,
  • Gösta Gahrton

Department of Hematology, Karolinska Institute at Karolinska University Hospital Huddinge, Stockholm, Sweden.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the Swedish Cancer Society and the Stockholm Cancer Society.

PII: S0037-1963(07)00126-6

doi:10.1053/j.seminhematol.2007.08.010

Seminars in Hematology
Volume 44, Issue 4 , Pages 227-233, October 2007

Article Tools

* Image Usage & Resolution